| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 10/04/2011 | US8029793 Anticancer agents; rheumatic diseases; osteoporosis; antiinflammatory agents; cloning genes |
| 10/04/2011 | US8029772 Free-flowing anionic surfactant, alkanolamide and electrolytemixture |
| 10/04/2011 | CA2669481C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels |
| 10/04/2011 | CA2615917C Use of lipoxin compounds for inhibiting of tnf-(alpha)initiated neutrophil response |
| 10/04/2011 | CA2494536C A 12-membered ring macrolide active substance |
| 10/04/2011 | CA2491079C Therapeutic piperazine derivatives useful for treating pain |
| 10/04/2011 | CA2481770C Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis |
| 10/04/2011 | CA2478099C Inhibitors |
| 10/04/2011 | CA2452871C Oxymorphone controlled release formulations |
| 10/04/2011 | CA2438520C Phthalazinone-piperidino-derivatives as pde4 inhibitors |
| 10/04/2011 | CA2434773C Piperazinylcarbonylquinolines and -isoquinolines |
| 09/29/2011 | WO2011119919A1 Adenosine compounds and their use thereof |
| 09/29/2011 | WO2011119759A1 Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
| 09/29/2011 | WO2011119722A2 Use of anatabine to treat inflammation and methods of synthesizing anatabine |
| 09/29/2011 | WO2011119461A1 1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds |
| 09/29/2011 | WO2011119011A2 Lipid emulsion having krill oil as an active ingredient and preparation method therefor |
| 09/29/2011 | WO2011118957A2 Composition for treating inflammatory, allergic or asthma diseases, containing paprika extracts |
| 09/29/2011 | WO2011118759A1 Benzanilide derivative |
| 09/29/2011 | WO2011118682A1 Aptamer for ngf and use thereof |
| 09/29/2011 | WO2011117749A1 Compound and method for the treatment of pain |
| 09/29/2011 | WO2011117711A1 Pharmaceutical composition comprising a pyrimidineone derivative |
| 09/29/2011 | WO2011117160A1 Pyrrolopyrazine derivatives and their use as jak and syk inhibitors |
| 09/29/2011 | WO2011117145A2 Pyrrolopyrazine kinase inhibitors |
| 09/29/2011 | WO2011116655A1 Antigen for increasing cd4+cd25+foxp3+ regulatory t cells and uses thereof |
| 09/29/2011 | WO2011059733A3 Use of lipoic acid in cell transplantation |
| 09/29/2011 | WO2011056604A3 Treatment of sunburn using analgesics and antihistamines |
| 09/29/2011 | WO2011046381A3 COMPOSITION FOR INHIBITING TGF-β COMPRISING IMIDAZOPURINE DERIVATIVES |
| 09/29/2011 | WO2010132370A3 Soluble tlt-1 for the treatment and diagnosis of sepsis |
| 09/29/2011 | WO2010127152A3 Compounds and compositions as microsomal prostaglandin e synthase-1 inhibitors |
| 09/29/2011 | US20110238016 Drug delivery to a joint |
| 09/29/2011 | US20110238003 Method for systemic drug delivery through the nail |
| 09/29/2011 | US20110238000 Polymer-conjugated albumin hydrogels for controlled release of therapeutic agents |
| 09/29/2011 | US20110237783 Hydrazonopyrazole derivatives and their use as therapeutics |
| 09/29/2011 | US20110237674 Topical nsaid compositions having sensate component |
| 09/29/2011 | US20110237660 Oral composition |
| 09/29/2011 | US20110237659 Chromenone derivatives as trpv3 antagonists |
| 09/29/2011 | US20110237658 Compound and method for the treatment of pain |
| 09/29/2011 | US20110237651 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo |
| 09/29/2011 | US20110237650 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf |
| 09/29/2011 | US20110237645 USE OF RNAi TECHNOLOGY TO INHIBIT ASIC3 |
| 09/29/2011 | US20110237635 Tetrahydronaphthalene derivatives |
| 09/29/2011 | US20110237619 Imidazopyridine derivatives which inhibit the secretion of gastric acid |
| 09/29/2011 | US20110237617 Thieno[2,3-c] isoquinolines for use as inhibitors of parp |
| 09/29/2011 | US20110237609 Antifolate compositions |
| 09/29/2011 | US20110237601 Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists |
| 09/29/2011 | US20110237598 New compounds |
| 09/29/2011 | US20110237596 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 09/29/2011 | US20110237592 Substituted amido phenoxybenzamides |
| 09/29/2011 | US20110237583 2, 5-diamino-substituted pyrido [4, 3-d] pyrimidines as autotaxin inhibitors against cancer |
| 09/29/2011 | US20110237581 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) |
| 09/29/2011 | US20110237574 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 09/29/2011 | US20110237572 Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives |
| 09/29/2011 | US20110237556 (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-HYDROXYVITAMIN D3 |
| 09/29/2011 | US20110237550 5-azaindole bisphosphonates |
| 09/29/2011 | US20110237546 Method for treating a mammal by administration of a compound having the ability to release co |
| 09/29/2011 | US20110237545 Trihydroxy polyunsaturated eicosanoid derivatives |
| 09/29/2011 | US20110237543 Composition for Prevention or Treatment of Eye Diseases |
| 09/29/2011 | US20110237536 Treating or Preventing Pain Using Spicamycin Derivatives |
| 09/29/2011 | US20110237532 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-xanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animal |
| 09/29/2011 | US20110237521 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 09/29/2011 | US20110237515 Peptide derived from neurotesin receptor 3 and use thereof in the treatment of psychiatric diseases |
| 09/29/2011 | US20110237498 Soluble polypeptides for use in treating autoimmune and inflammatory disorders |
| 09/29/2011 | US20110237492 Treatment of diseases and conditions mediated by increased phosphorylation |
| 09/29/2011 | US20110236499 Dermal compositions containing gorgonian extract |
| 09/29/2011 | US20110236491 Topical anti-inflammatory composition |
| 09/29/2011 | US20110236460 Therapeutic Implant |
| 09/29/2011 | US20110236455 Novel Regulators of the Innate Immune System |
| 09/29/2011 | US20110236438 Method of treatment of diseases using hoodia extracts |
| 09/29/2011 | US20110236429 Small Cationic Antimicrobial Peptides |
| 09/29/2011 | US20110236401 Compositions and methods for modulating lymphocyte activity |
| 09/29/2011 | US20110236400 Tetrahydropyranochromene gamma secretase inhibitors |
| 09/29/2011 | US20110236398 Antibody Formulation |
| 09/29/2011 | US20110236390 IL-17A Antagonists |
| 09/29/2011 | US20110236367 Rat cathespin dipeptidyl peptidase i (dppi): crystal structure and its uses |
| 09/29/2011 | US20110236352 PEGylation by the Dock and Lock (DNL) Technique |
| 09/29/2011 | US20110236325 Methods to treat or prevent a skin condition using a nell1 peptide |
| 09/29/2011 | US20110236317 Tetrahydrotriazine compounds for treating diseases associated with ampk acitivity |
| 09/29/2011 | US20110236312 Nucleoside analogues useful as positron emission tomography (pet) imaging agents |
| 09/29/2011 | CA2794199A1 Aptamer for ngf and use thereof |
| 09/29/2011 | CA2794097A1 Use of anatabine to treat inflammation and methods of synthesizing anatabine |
| 09/29/2011 | CA2792265A1 Adenosine compounds and their use thereof |
| 09/29/2011 | CA2789900A1 Pharmaceutical composition comprising a pyrimidineone derivative |
| 09/29/2011 | CA2786900A1 Pyrrolopyrazine kinase inhibitors |
| 09/29/2011 | CA2786402A1 Pyrrolopyrazine derivatives and their use as jak and syk inhibitors |
| 09/28/2011 | EP2368910A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 09/28/2011 | EP2368898A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 09/28/2011 | EP2368886A1 Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease |
| 09/28/2011 | EP2367830A1 1-oxa-8-azaspiro [4, 5] decane- 8 -carboxamide compounds as faah inhibitors |
| 09/28/2011 | EP2367825A1 Fused imidazole carboxamides as trpv3 modulators |
| 09/28/2011 | EP2367812A2 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4trifluoromethoxy-1h-indol-3-yl]methanone as an inhibitor of mast cell tryptase |
| 09/28/2011 | EP2367801A1 Polar quinazolines as liver x receptors ( lxrs ) modulators |
| 09/28/2011 | EP2367546A1 Local anesthetic for relieving breast pain |
| 09/28/2011 | EP2244703B1 Pharmaceuticals and the production and use thereof in the treatment of painful neuropathies |
| 09/28/2011 | EP2133335B1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 09/28/2011 | EP1885704B1 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof |
| 09/28/2011 | EP1421191B1 Humanised antibodies specific for both CD45RB and CD45RO |
| 09/28/2011 | EP1237891B1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 09/28/2011 | CN1994380B Externally applied medicine for treating arthritis, hot pack and preparation method thereof |
| 09/28/2011 | CN1994343B Pharmaceutical composition having functions in activating blood and invigorating qi and preparation process thereof |
| 09/28/2011 | CN1907350B Composition, extract thereof and its pharmaceutical use |